These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29532913)
1. Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia. Castillo JJ; Gustine JN; Meid K; Dubeau T; Severns P; Xu L; Yang G; Hunter ZR; Treon SP Br J Haematol; 2019 Mar; 184(6):1011-1014. PubMed ID: 29532913 [No Abstract] [Full Text] [Related]
2. Waldenstrom macroglobulinaemia manifesting as acquired von Willebrand syndrome. Mohamed M Intern Med J; 2018 Jul; 48(7):888-891. PubMed ID: 29984508 [No Abstract] [Full Text] [Related]
3. [Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP]. Thies K; Budde U; Hellstern P Beitr Infusionsther; 1990; 26():179-82. PubMed ID: 1703824 [TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand disease: potential contribution of the von Willebrand factor collagen-binding to the identification of functionally inhibiting auto-antibodies to von Willebrand factor: a rebuttal. Guerin V; Ryman A; Velez F J Thromb Haemost; 2008 Jun; 6(6):1051-2. PubMed ID: 18384652 [No Abstract] [Full Text] [Related]
5. Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome. Coucke L; Marcelis L; Deeren D; Van Dorpe J; Lambein K; Devreese K Blood Coagul Fibrinolysis; 2014 Jun; 25(4):395-7. PubMed ID: 24469392 [TBL] [Abstract][Full Text] [Related]
6. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia. Gustine JN; Meid K; Dubeau T; Hunter ZR; Xu L; Yang G; Ghobrial IM; Treon SP; Castillo JJ Br J Haematol; 2017 Jun; 177(5):717-725. PubMed ID: 28485115 [TBL] [Abstract][Full Text] [Related]
7. Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia. Tripsas CK; Patterson CJ; Uljon SN; Lindeman NI; Turnbull B; Treon SP Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):250-2. PubMed ID: 23664027 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells. de Tute RM; Rawstron AC; Owen RG Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):211-3. PubMed ID: 23523273 [TBL] [Abstract][Full Text] [Related]
13. Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variants. Casonato A; Fabris F; De Marco L; Girolami A Blut; 1987 Jul; 55(1):61-2. PubMed ID: 3496930 [No Abstract] [Full Text] [Related]
14. Discrepancy in von Willebrand factor activity determined by ristocetin cofactor and immunotubidometric assays. Reilly-Stitt C; Coppell J; Mumford AD Haemophilia; 2014 Jul; 20(4):e341-4. PubMed ID: 24758483 [No Abstract] [Full Text] [Related]
15. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma. Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534 [TBL] [Abstract][Full Text] [Related]
16. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Siaka C; Rugeri L; Caron C; Goudemand J Haemophilia; 2003 May; 9(3):303-8. PubMed ID: 12694522 [TBL] [Abstract][Full Text] [Related]
18. Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: is there a clinical relevance? Kertzscher F; Müller AE; Lenk H Eur J Pediatr; 1999 Dec; 158 Suppl 3():S177-9. PubMed ID: 10650864 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity. Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406 [TBL] [Abstract][Full Text] [Related]
20. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I; Morris D; Konkle BA Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]